Related Experiment Videos
Differences between early and late-onset Alzheimer's disease.
1Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories Terlings Park, Harlow, England.
Neurobiology of Aging
|November 1, 1987
Summary
Early-onset Alzheimer's disease presents distinct neuropathologies compared to late-onset forms. This early-onset Alzheimer's involves more severe neuronal loss and broader neurochemical changes.
Area of Science:
- Neuroscience
- Neuropathology
- Alzheimer's Disease Research
Background:
- Alzheimer's disease (AD) is broadly categorized into early-onset and late-onset forms.
- These forms are increasingly recognized as distinct clinical and pathological entities.
- Understanding these differences is crucial for targeted research and treatment.
Purpose of the Study:
- To delineate the distinct neuropathological features of early-onset Alzheimer's disease (EOAD) compared to late-onset Alzheimer's disease (LOAD).
- To investigate the specific neurochemical alterations associated with EOAD.
Main Methods:
- Comparative neuropathological analysis of brain tissue from EOAD and LOAD patients.
- Assessment of neuronal loss in cortical and sub-cortical regions.
- Neurochemical profiling to identify affected neurotransmitter systems.
Main Results:
- EOAD is characterized by more severe and widespread neuronal loss in both cortical and sub-cortical areas compared to LOAD.
- Neurochemical alterations in EOAD extend beyond the cholinergic system.
- Specific involvement of GABA, somatostatin, and norepinephrine systems was observed in EOAD.
Conclusions:
- Early-onset Alzheimer's disease represents a distinct clinicopathological syndrome.
- The broader neuropathology and neurochemical deficits in EOAD suggest unique underlying mechanisms.
- Further research into these specific pathways may reveal novel therapeutic targets for EOAD.